Stem cell transplant alleviates symptoms in lupus animal models

Researchers in Korea have discovered that adult mesenchymal stem cells (MSCs) may help to reduce inflammation in mice suffering from Lupus. The discovery came after researchers injected mice suffering from systemic lupus erythematosus (SLE), an autoimmune disease that produces immune reactions which leads to a variety of symptoms including kidney inflammation or nephritis, with adult stem cells derived from human bone marrow. The mice injected with these MSCs experienced a reduction in inflammation as well as attenuated nephritis. The injection … read more

Mesenchymal Stem Cells May Hold The Answer to Fighting Type 1 Diabetes

Diabetes affects over 25.8 million people in the United States and its numbers are continuing to grow. Type 1 diabetes (T1D), or juvenile diabetes, affects 5-10% of the total diabetic population. Type 1 diabetes is a chronic autoimmune disease that causes destruction of pancreatic B cells, which ultimately result in loss of insulin production. Recent clinical trials have found that Mesenchymal Stem Cells (MSCs) may be an alternative to treating T1D. MSCs, (the same type of cells used by Celltex), … read more

Stem Cell Therapy May Improve Outcomes in Knee Surgery and Osteoarthritis: Optimum Performance

A research article published by the Journal of Bone and Joint Surgery ( found that mesenchymal stem cells (MSCs) have the potential to improve knee joints after surgery.  The study, a phase I/II randomized, double blind, controlled study of MSCs that were delivered by a single injection after a knee surgery, involved 60 patients between the ages of 16 and 60. At the end of the study, those who were injected with adult MSCs saw an improvement in knee pain … read more

Walking Miracles: Houston-area JIA duo complete Walk to Cure Arthritis 5K after stem cell therapy

Celltex Therapeutics Corporation superheroes, 24-year-old Sarah Hughes and seven-year-old Tucker Beau Hyatt, were able to complete, for the first time ever, the annual Walk to Cure Arthritis on Saturday, May 16. Diagnosed with systemic Juvenile Idiopathic Arthritis (JIA) at a young age, the duo attended last year’s 2014 Walk to Cure Arthritis, but were not physically able to walk with their teams. Both were pushed, in a wheelchair and stroller, respectively, for one-half mile but had to stop and go … read more

Study Showing How Stem Cells Slow Aging May Lead to New Heart Failure Treatments

Dr. Yanjie Lu, M.D, Ph.D., a professor at Harbin Medical University in China and a world-renowned expert on myocardial infarction has published a study in STEM CELLS Translational Medicine on mesenchymal stem cells (MSCs) and their potential to protect the heart from further damage after a cardiac incident. The study, which involved studying rats who had been injected with MSCs, could promote stem cells as a potential treatment for heart conditions. Not only does the study show that MSCs can … read more

Virtuosi of Houston Honors Celltex CEO David Eller for Excellence in Business

On Saturday, April 25, Celltex Therapeutics Corporation Founder and CEO, David Eller, was honored by Virtuosi of Houston as a top Entrepreneur in Houston. The “Legends of the Future: Celebrating Heroines & Heroes Gala” was held at the Royal Sonesta Hotel and included a concert by the talented young musicians of Virtuosi Houston. Every year, the Virtuosi of Houston Organization honors local Houston area “Heroines & Heroes,” who have excelled in their area of business. These men and women have … read more

Study Promotes Bone Growth as Possible Therapy for Osteoporosis and Obesity

Dr. Joshua Hare, M.D. director of the interdisciplinary stem cell institute at the Miller School of Medicine, and his team have authored a new study demonstrating that mesenchymal stem cells can create bone cells by triggering a biochemical switch. The study was conducted using mice that lacked the enzyme that regulates the body’s level of nitric oxide, a molecule which helps transmit signals throughout the body. When MSCs were inserted into the mice, it was found that the mice produced … read more

Texas Native Sees Remarkable Improvement in Battle With Multiple Sclerosis After Stem Cell Therapy

March is the official month of National MS Awareness. More than 2.3 million people worldwide suffer from multiple sclerosis (MS), a chronic disease in which the immune system incorrectly attacks healthy tissue in a person’s central nervous system. While MS is not a fatal disease, it affects a person’s vision and mobility, and can even cause paralysis in severe cases. There is no cure for MS, however, Celltex Therapeutics is using its proprietary stem cell culturing and banking technology to … read more

Local Alzheimer’s Association tours Celltex lab, learns more about stem cell banking and therapy

On Tuesday, Feb. 10, Celltex met with the Alzheimer’s Association Houston & Southeast Texas Chapter to provide a tour for their staff members through the stem cell processing and culturing lab and share the potential of stem cell use in regenerative therapies. This private tour is part of Celltex’s educational outreach initiatives aimed at engaging local organizations whose focus is on helping those with degenerative and autoimmune diseases and sharing information and resources about stem cell therapy that may benefit … read more

Mayo Clinic

Diagnosed in 2006 with renal artery stenosis, Ralph Johnsen was desperate for options. Johnsen turned to physicians at the Mayo Clinic, who were conducting a clinical trial in which an individual’s own stem cells were being used to repair a person’s  arteries and damaged tissues. Due to the overwhelming success of the trial and the large amount of “proof of concept data,” the National Institutes of Health agreed to provide funding for a five-year study, which began in 2014. Click … read more